|
1
|
O’Brien S, Thall PF and Siciliano MJ:
Cytogenetics of chronic myelogeneous leukaemia. Baillieres Clin
Hematol. 10:259–276. 1997.
|
|
2
|
Shtivelman E, Lifshitz B, Gale RP and
Canaani E: Fused transcript of abl and bcr genes in chronic
myelogenous leukemia. Nature. 315:550–554. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Anastasi J, Feng J, Le Beau MM, Larson RA,
Rowley JD and Vardiman JW: The relationship between secondary
chromosomal abnormalities and blast transformation in chronic
myelogenous leukemia. Leukemia. 9:628–633. 1995.PubMed/NCBI
|
|
4
|
Whang-Peng J, Knutsen TA and Lee EC:
Dicentric Ph1 chromosome. J Natl Cancer Inst. 51:2009–2012.
1973.
|
|
5
|
Becher R, Ohl S, Schaefer UW, Wendehorst
E, Quiskamp F, Mahmoud HK, Schüning F and Schmidt CG: Clonal
evolution with isodicentric Ph1 chromosome in Ph1-positive CML:
karyotypic conversion after bone marrow transplantation. Blut.
48:247–250. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kovacs G, Georgii A and Mainzer K: Three
isodicentric Philadelphia chromosomes in acute phase of chronic
myeloid leukemia: a case report. Cancer Genet Cytogenet. 20:29–33.
1986. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Pernice F, Squadrito G, Saitta A, Mazza G
and Musolino C: Isodicentric Philadelphia chromosome in accelerated
phase of chronic myeloid leukemia. Cancer Genet Cytogenet.
66:113–116. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Szych CM, Liesveld JL, Iqbal MA, Li L,
Siebert S, Asmus C, O’Malley J, Lee A and Wang N: Isodicentric
Philadelphia chromosomes in imatinib mesylate (Gleevec)-resistant
patients. Cancer Genet Cytogenet. 174:132–137. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li Ming Chua C, Tan YY, Chua SP, Ma HB,
Koay E, Li Min Poon M, Liu TC and Gole L: Multiple copies of a rare
rearrangement of Philadelphia chromosome in a chronic myeloid
leukemia patient: a case report. Cancer Genet Cytogenet. 199:66–68.
2010.PubMed/NCBI
|
|
10
|
Yamamoto K, Nagata K, Morita Y, Inagaki K
and Hamaguchi H: Isodicentric Philadelphia chromosome in acute
lymphoblastic leukemia with der(7;12)(q10;q10). Leuk Res.
31:713–718. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gambacorti-Passerini CB, Gunby RH, Piazza
R, Galietta A, Rostagno R and Scapozza L: Molecular mechanisms of
resistance to imatinib in Philadelphia-chromosome-positive
leukaemias. Lancet Oncol. 4:75–85. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
O’Brien SG, Guilhot F, Larson RA, Gathmann
I, Baccarani M, Cervantes F, Cornelissen JJ, Fischer T, Hochhaus A,
Hughes T, Lechner K, Nielsen JL, Rousselot P, Reiffers J, Saglio G,
Shepherd J, Simonsson B, Gratwohl A, Goldman JM, Kantarjian H,
Taylor K, Verhoef G, Bolton AE, Capdeville R and Druker BJ; IRIS
Investigators: Imatinib compared with interferon and low-dose
cytarabine for newly diagnosed chronic-phase chronic myeloid
leukemia. N Engl J Med. 348:994–1004. 2003.
|
|
13
|
Kantarjian H, Sawyers C, Hochhaus A,
Guilhot F, Schiffer C, Gambacorti-Passerini C, Niederwieser D,
Resta D, Capdeville R, Zoellner U, Talpaz M and Druker B:
Hematologic and cytogenetic responses to imatinib mesylate in
chronic myelogenous leukemia. N Engl J Med. 346:645–652. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Talpaz M, Silver RT, Druker BJ, Goldman
JM, Gambacorti-Passerini C, Guilhot F, Schiffer CA, Fischer T,
Deininger MWN, Lennard AL, et al: Imatinib induces durable
hematologic and cytogenetic responses in patients with accelerated
phase chronic phase chronic myeloid leukemia: results of a phase 2
study. Blood. 99:1928–1937. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sawyers CL, Hochhaus A, Feldman E, Goldman
JM, Miller CB, Ottmann OG, Schiffer CA, Talpaz M, Guilhot F,
Deininger MWN, et al: Imatinib induces hematologic and cytogenetic
responses in patients with chronic myelogenous leukemia in myeloid
blast crisis: results of a phase II study. Blood. 99:3530–3539.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hochhaus A, Kreil S, Corbin AS, La Rosée
P, Müller MC, Lahaye T, Hanfstein B, Schoch C, Cross NCP, Berger U,
Gschaidmeier H, Druker BJ and Hehlmann R: Molecular and chromosomal
mechanisms of resistance to imatinib (STI571) therapy. Leukemia.
16:2190–2196. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Al-Achkar W, Wafa A and Nweder MS: A
complex translocation t(5;9;22) in Philadelphia cells involving the
short arm of chromosome 5 in a case of chronic myelogenous
leukemia. J Exp Clin Cancer Res. 26:411–415. 2007.PubMed/NCBI
|
|
18
|
Shaffer L, Slovak M and Campbell L: ISCN
(2009): An International System for Human Cytogenetic Nomenclature.
S. Karger; Basel: 2009
|
|
19
|
Trifonov V, Seidel J, Starke H, Martina P,
Beensen V, Ziegler M, Hartmann I, Heller A, Nietzel A, Claussen U
and Liehr T: Enlarged chromosome 13 p-arm hiding a cryptic partial
trisomy 6p22.2-pter. Prenat Diagn. 23:427–430. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ewers E, Yoda K, Hamid AB, Weise A,
Manvelyan M and Liehr T: Entromere activity in dicentric small
supernumerary marker chromosomes. Chromosome Res. 18:555–562. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Al-Achkar W, Wafa A, Ali BY, Manvelyan M
and Liehr T: A rare chronic myeloid leukemia case with Philadelphia
chromosome, BCR-ABL e13a3 transcript and complex translocation
involving four different chromosomes. Oncol Lett. 1:797–800.
2010.PubMed/NCBI
|
|
22
|
Barnes DJ, Palaiologou D, Panousopoulou E,
Schultheis B, Yong AS, Wong A, Pattacini L, Goldman JM and Melo JV:
Bcr-Abl expression levels determine the rate of development of
resistance to imatinib mesylate in chronic myeloid leukemia. Cancer
Res. 65:8912–8919. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Le Coutre P, Tassi E, Varella-Garcia M,
Barni R, Mologni L, Cabrita G, Marchesi E, Supino R and
Gambacorti-Passerini C: Induction of resistance to the Abelson
inhibitor STI571 in human leukemic cells through gene
amplification. Blood. 95:1758–1766. 2000.PubMed/NCBI
|
|
24
|
Campbell LJ, Patsouris C, Rayeroux KC,
Somana K, Januszewicz EH and Szer J: BCR/ABL amplification in
chronic myelocytic leukemia blast crisis following imatinib
mesylate administration. Cancer Genet Cytogent. 139:30–33. 2002.
View Article : Google Scholar : PubMed/NCBI
|
